Plunkett Research Online: Amarin Corporation plc

AMARIN CORPORATION PLC (AMRN:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Amarin Corporation plc is a biopharmaceutical company focused on cardiovascular disorders. The company’s platforms utilize the cardiovascular system’s innate quality of being affected by polyunsaturated fatty acids. Amarin’s lipophilic drugs are fat-soluble, allowing easy transportation across the.....



Amarin Corporation plc
Ticker: AMRN
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 353 1 6699 020
Fax:
Address: Upper Pembroke Street 28-32
2 Pembroke House
Dublin, 2 Ireland

Types Of Business
Industry Ranks

Industry NAICS code:

Drugs, Cardiovascular
Drugs, Cardiovascular Health
Drugs, Triglyceride Reduction
ContactsDescription
Michael KalbAssistant Secretary/CFO/Chief Accounting Officer/Senior VP
John TheroCEO/Director/President
See More
Amarin Corporation plc is a biopharmaceutical company focused on cardiovascular disorders. The company’s platforms utilize the cardiovascular system’s innate quality of being affected by polyunsaturated fatty acids. Amarin’s lipophilic drugs are fat-soluble, allowing easy transportation across the.....See More See More

Auditor: Ernst & Young LLP
Legal Advisor: K&L Gates LLP
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Vascepa
REDUCE-IT
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: